Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data RxSight, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
14.7
22.6
49
89.1
140
134
Cost of revenue
13
18.1
27.7
35.3
41
31.5
Gross profit
1.71
4.52
21.3
53.8
98.9
103
Research and development
21.9
24.5
26
29.1
34.4
38.5
Selling, general and administrative
15.2
32.8
58.7
74.8
101
113
Operating expenses
37.1
57.3
84.6
104
136
151
Operating income
-35.4
-52.8
-63.3
-50.1
-36.9
-48.2
Interest expense
0.51
3.68
4.95
3.31
0.02
0.02
Pre-tax income
27.6
-48.7
-66.7
-48.6
-27.4
-38.9
Income tax
0.06
0.01
0.01
0.02
0.05
0.07
Net income
27.6
-48.7
-66.8
-48.6
-27.5
-38.9
EBITDA
-31.6
-48.8
-59.4
-46
-33.3
-44.9
EPS, basic
0.91
-3.57
-2.41
-1.41
-0.71
-0.95
EPS, diluted
0.15
-3.57
-2.41
-1.41
-0.71
-0.95
Shares, basic (weighted)
3.71
13.6
27.7
34.5
38.9
40.9
Shares, diluted (weighted)
5.53
13.6
27.7
34.5
38.9
40.9
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
14
24.4
11.8
9.69
16.7
19.9
Short-term investments
55
135
94
117
221
208
Receivables
2.87
4.86
11
20.3
30.1
23.4
Inventory
8.29
8.03
14.8
17.4
22
31.6
Other current assets
1.37
4.07
2.96
3.52
4.54
4.39
Total current assets
81.5
176
135
168
294
287
Property, plant and equipment
13.3
11.2
10.1
10.8
12.4
13.1
Lease right-of-use assets
5.32
4.28
3.94
2.44
11.2
9.96
Other non-current assets
0.11
0.11
0.77
0.15
0.36
0.59
Total assets
101
193
150
183
319
312
Accounts payable
1.13
1.69
2.6
3.86
4.54
5.3
Accrued liabilities
4.17
7.86
12.7
15.2
20.4
19.8
Deferred revenue
0.42
0.62
1.35
2.05
3.11
3.6
Total current liabilities
11.6
11.1
17.2
20.9
25.9
26.3
Lease liabilities
5.04
3.63
2.81
1.09
11.2
9.81
Total liabilities
44.9
54.5
60.3
22.2
37.3
36.1
Total debt
24.4
39.8
40.2
0
Paid-in capital
0
618
636
755
903
937
Retained earnings
-431
-479
-546
-595
-622
-661
Other comprehensive income
-0
-0.02
-0.1
-0.01
0.17
0.05
Shareholders' equity
-431
138
89.9
160
281
276
Total equity
-431
138
89.9
160
281
276
Total liabilities and equity
101
193
150
183
319
312
Shares outstanding
27.4
28.3
36.1
40.4
41.2
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
27.6
-48.7
-66.8
-48.6
-27.5
-38.9
Depreciation and amortization
3.85
3.98
3.88
4.08
3.58
3.27
Stock-based compensation
4.19
7.58
11.4
15.7
24.6
31.6
Deferred income tax
-9.82
-13.2
14.9
12.8
19.1
6.54
Change in receivables
-2.08
-2
-6.09
-9.33
-9.8
6.66
Change in inventory
-1.31
-2.11
-7.56
-2.75
-4.99
-11.5
Change in payables
-0.95
0.56
0.64
1.25
0.95
0.63
Cash from operations
-35.2
-44.7
-58.9
-41.6
-16.9
-15.5
Capital expenditures
-2.54
-1.94
-2.39
-4.81
-5.44
-3.83
Purchases of investments
-97.9
-160
-213
-272
-337
-239
Cash from investing
15.6
-81.9
40
-22.1
-99.3
16.9
Stock issued
0.99
12.4
1.78
9.47
20.8
3.95
Cash from financing
25.2
137
6.33
61.5
123
1.86
Exchange rate effect
0
-0.01
-0.01
0.01
-0.01
0
Net change in cash
5.63
10.7
-12.6
-2.19
7.05
3.24
Free cash flow
-37.7
-46.6
-61.2
-46.4
-22.4
-19.3
Income taxes paid
0.06
0.02
0
0.01
0.02
0.06
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.66 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
77.5%
Gross profit / revenue.
Operating margin
-43.2%
Operating income / revenue.
EBITDA margin
-40.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-36.7%
Pre-tax income / revenue.
Net margin
-36.8%
Net income / revenue.
FCF margin
-21.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-17.8%
Cash from operations / revenue.
Return on equity (ROE)
-17.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-13.3%
Net income / average total assets.
Return on invested capital (ROIC)
-17.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
28.7%
Research and development expense / revenue.
SG&A / revenue
92.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
24.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.5%
Capital expenditures / revenue.
D&A / revenue
2.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-3.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
40.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
55.7%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
4.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
69.0%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
127.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-2.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
45.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-2.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
27.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
25.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
5.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
13.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
49.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.07x
Current assets / current liabilities.
Quick ratio
2.83x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.60x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.13
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$3.07
Revenue / diluted weighted shares.
FCF per share
-$0.65
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.55
Cash from operations / diluted weighted shares.
Book value per share
$6.33
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.52x
Market cap / revenue.
P/B
0.74x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.74x
Market cap / tangible book value, when positive.
FCF yield
-14.0%
Free cash flow / market cap.
Earnings yield
-24.2%
Net income / market cap (the inverse of P/E).
What was RxSight, Inc.'s revenue in fiscal 2025?
RxSight, Inc. reported revenue of $134.5M for fiscal 2025, 3.9% lower than the year before.
Was RxSight, Inc. profitable in fiscal 2025?
No. It reported a net loss of $38.9M.
How much free cash flow did RxSight, Inc. generate in fiscal 2025?
Cash from operations of $15.5M minus capital expenditures of $3.8M left free cash flow of -$19.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.